Get started
Work

Resistance-associated amino acid variants associated with boceprevir plus pegylated interferon-α2b and ribavirin in patients with chronic hepatitis C in the SPRINT-1 Trial F

Year: 2013
Type: article
DOI: 10.3851/imp2549
Authors: Robert A Ogert, John A Howe, John M Vierling, Paul Y Kwo, Eric J Lawitz, Jonathan McCone, Eugene R Schiff, David Pound, Mitchell N Davis, Stuart C Gordon, Natarajan Ravendhran, Lorenzo Rossaro, Ira M Jacobson, Robert Ralston, Eirum Chaudhri, Ping Qiu, Lisa D Pedicone, Clifford A Brass, Janice K Albrecht, Richard JO Barnard, Daria J Hazuda, Anita YM Howe
Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Baylor College of Medicine, Indiana University – Purdue University Indianapolis, University of Miami, Digestive CARE, Henry Ford Health, University of Maryland, Baltimore, University of California, Davis, Cornell University
Language: English
Subfield: Hepatology
Field: Medicine
Open Access status: closed
OpenAlex ID: W111705748
FWCI: 3.106
Cites: 26
Cited by: 21
Related to: 10